Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Inventory (2024 - 2026)

Carlsmed filings provide 2 years of Inventory readings, the most recent being $1.8 million for Q4 2025.

  • On a quarterly basis, Inventory rose 85.43% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 85.43% increase, with the full-year FY2025 number at $1.8 million, up 85.43% from a year prior.
  • Inventory hit $1.8 million in Q4 2025 for Carlsmed, up from $1.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.8 million in Q4 2025 to a low of $995000.0 in Q4 2024.